معرفی
Dr. Konstantinos Neochoritis is an Associate Professor in the Department of Chemistry at the University of Crete, Greece. He leads the Neochoritis Research Group, which focuses on synthetic organic chemistry with special emphasis on Multi-Component Reactions (MCRs) and their applications in pharmaceutical and materials chemistry. His research has significant implications for drug discovery and the development of novel therapeutic agents.
Education:
- 2004: Graduate, Department of Chemistry, Aristotle University of Thessaloniki
- 2006: Postgraduate Diploma, Department of Chemistry, Aristotle University of Thessaloniki
- 2011: PhD in Organic Chemistry, Department of Chemistry, Aristotle University of Thessaloniki (Thesis: "Synthesis of biologically active heterocyclic compounds")
Dr. Neochoritis' research focuses on the synthesis and study of functional molecules through Multi-Component Reactions (MCRs), with applications spanning pharmaceutical chemistry and materials science. His work bridges fundamental organic chemistry with practical applications in drug discovery, particularly in cancer immunotherapy. The group's approach emphasizes diversity generation, complexity creation, and resource efficiency in synthetic pathways.
Analysis of his recent publications (2023-2025) reveals a strong focus on innovative applications of MCRs, particularly in the development of molecular tools for protein-protein interactions, atropisomeric compounds with potential therapeutic applications, and novel heterocyclic scaffolds. His work demonstrates a clear trajectory toward increasingly complex molecular architectures with biological relevance, especially in breast cancer therapeutics and inflammation-related diseases.
Scientific Awards:
- Excellence scholarship from the Research Committee of Aristotle University of Thessaloniki (PhD studies)
- Excellence in Postdoctoral Researchers scholarship from the Research Committee of Aristotle University of Thessaloniki
Dr. Neochoritis has successfully mentored numerous students at various levels, including current MSc students and past BSc, MSc, and PhD candidates. His research is supported by funding from the Hellenic Foundation for Research & Innovation (HFRI), ELKE@UoC, and his pharmaceutical company TelesisPharma. He also collaborates with the Empirikion Foundation, indicating strong industry-academic partnerships.
The Neochoritis Research Group operates from laboratory A311 in the Chemistry Department at the University of Crete. The group consists of current MSc students and has previously hosted postdoctoral researchers. Their work is characterized by a collaborative approach, with frequent co-authorship among group members and external collaborators from institutions like the University of Groningen. The group's research is poised to make significant contributions to the fields of medicinal chemistry and synthetic methodology.
